CAS 121650-80-4: Pancopride

Pancopride(LAS 30451) is a novel, orally available, long-acting, selective 5-HT3 receptor antagonist that blocks nitrogen mustard and dacarbazine-induced

Pancoprida is a bioactive peptide, which is a synthetic compound derived from rational peptide design and combinatorial chemistry techniques. It functions through the modulation of specific receptor pathways, primarily targeting neuronal and inflammatory processes. Pancoprida exhibits high affinity for serotonin receptors, influencing neurotransmitter release and uptake, and also modulates certain cytokine pathways, thereby reducing inflammation. This compound is utilized in preclinical models to explore its potential therapeutic applications in neurodegenerative diseases and inflammatory disorders. Research is ongoing to evaluate its efficacy and safety profile. Pancoprida's action on serotonin receptors also opens avenues for investigating its role in managing psychiatric conditions such as depression and anxiety. Scientists are particularly interested in its ability to cross the blood-brain barrier, a crucial property for central nervous system-targeted therapies. Current studies focus on refining its delivery methods and understanding its long-term impact on systemic physiological processes.